Video

Dr Soumya Vishwanath Highlights Tools for Assessing the Effectiveness of Digital Therapeutics

Author(s):

Health plans and payers have plenty of options for how to analyze the effectiveness of digital therapeutic tools, as there are several effective strategies, according to Soumya Vishwanath, PharmD, of Magellan Rx Management.

Health plans and payers have plenty of options for how to analyze the effectiveness of digital therapeutic tools as there are several effective strategies, according to Soumya Vishwanath, PharmD, senior manager of Formulary Management at Magellan Rx Management, at the Academy of Managed Care Pharmacy's annual meeting.

Transcript

What are some of the different strategies that health systems have implemented to assess the effectiveness of digital therapeutic tools?

Some of the strategies that some health plans and payers have implemented are creating an objective criteria on how to review digital therapeutics products based on priorities that are important to them. So, recognizing what's the scope that they want to evaluate; whether it's digital health, digital medicine, digital therapeutics, or a scope in a specific disease state. That's a great objective start to reviewing and evaluating these products and understanding whether it would serve their patient population and be appropriate for their formulary.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Dr Pankit Vachhani
Mansi Shah, MD
Dr John Mascarenhas
CK Wang, MD, COTA
Dr Pankit Vachhani
Screenshot of Ivo Abraham, PhD, RN, during a video interview
Merrill H. Stewart, MD
Dr John Mascarenhas
Carla Nester, MD, MSA, FASN, Stead Family Children's Hospital
Dr John Mascarenhas
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo